These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1681579)

  • 1. University of California/Davis Interdepartmental Conference on gram-negative septicemia.
    Young LS; Proctor RA; Beutler B; McCabe WR; Sheagren JN
    Rev Infect Dis; 1991; 13(4):666-87. PubMed ID: 1681579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gram-negative sepsis: a dilemma of modern medicine.
    Bone RC
    Clin Microbiol Rev; 1993 Jan; 6(1):57-68. PubMed ID: 8457980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adoptive immunotherapy of gram-negative sepsis: use of monoclonal antibodies to lipopolysaccharide.
    Fink MP
    Crit Care Med; 1993 Feb; 21(2 Suppl):S32-9. PubMed ID: 8428494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endotoxemia and gram-negative bacteremia in swine: chemical mediators and therapeutic considerations.
    Olson NC; Dodam JR; Kruse-Elliott KT
    J Am Vet Med Assoc; 1992 Jun; 200(12):1884-93. PubMed ID: 1639693
    [No Abstract]   [Full Text] [Related]  

  • 6. Passive immunotherapy of gram-negative bacteremia, sepsis and septic shock.
    Spapen HD; Diltoer M; Huyghens LP
    Acta Clin Belg; 1993; 48(1):20-9. PubMed ID: 7684546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.
    McCloskey RV; Straube RC; Sanders C; Smith SM; Smith CR
    Ann Intern Med; 1994 Jul; 121(1):1-5. PubMed ID: 8198341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of endotoxin activity.
    Schletter J; Heine H; Ulmer AJ; Rietschel ET
    Arch Microbiol; 1995 Dec; 164(6):383-9. PubMed ID: 8588739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human monoclonal antibody against endotoxin.
    Zarowitz BJ
    DICP; 1991; 25(7-8):778-83. PubMed ID: 1949939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock.
    Uriu K; Osajima A; Hiroshige K; Watanabe H; Aibara K; Inada Y; Segawa K; Anai H; Takagi I; Ito A; Kamochi M; Kaizu K
    Am J Kidney Dis; 2002 May; 39(5):937-47. PubMed ID: 11979337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody to endotoxin in the treatment of gram-negative sepsis.
    McCabe WR
    JAMA; 1992 May; 267(17):2325; author reply 2326. PubMed ID: 1564763
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody to endotoxin in the treatment of gram-negative sepsis.
    van Deventer S
    JAMA; 1992 May; 267(17):2325-6. PubMed ID: 1564765
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiendotoxin antibodies: a dead end?
    Cross AS
    Ann Intern Med; 1994 Jul; 121(1):58-60. PubMed ID: 8198349
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe Ebola virus infection complicated by gram-negative septicemia.
    Kreuels B; Addo MM; Schmiedel S
    N Engl J Med; 2015 Apr; 372(14):1377. PubMed ID: 25830439
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe Ebola virus infection complicated by gram-negative septicemia.
    Plachouras D; Monnet DL; Catchpole M
    N Engl J Med; 2015 Apr; 372(14):1376-7. PubMed ID: 25830440
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiendotoxin antibodies.
    Siegel JP
    Ann Intern Med; 1995 Feb; 122(4):315-6. PubMed ID: 7825773
    [No Abstract]   [Full Text] [Related]  

  • 17. Gram-negative septicemia and shock.
    Craig CP
    Compr Ther; 1982 Feb; 8(2):13-8. PubMed ID: 7067384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of gram-negative bacteraemia in sepsis syndrome. Implications for immunotherapy.
    Willatts SM; Speller DC; Winter RJ
    Anaesthesia; 1994 Sep; 49(9):751-4. PubMed ID: 7978126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 'sticky' problem of Staphylococcus epidermidis sepsis.
    Christensen GD
    Hosp Pract (Off Ed); 1993 Sep; 28(9A):27-36, 38. PubMed ID: 8408357
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of monoclonal antibodies in the management of gram-negative sepsis. Experience with the E5 antibody.
    Gorelick KJ; Chmel H
    Infect Dis Clin North Am; 1991 Dec; 5(4):899-913. PubMed ID: 1783775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.